You appear to be offline. Some data may be unavailable until your connection is restored.

RVTY

Stock

Revvity Inc

Create price alert
$157.02
-$1.23 (0.78%)
At close: Nov 12, 2026, 4:00 PM

Description

Revvity, Inc. provides health‑science solutions that include analytical instruments, reagents, antibodies, informatics software and diagnostic platforms for both research laboratories and clinical testing labs. The company operates in the life‑sciences and diagnostics segments of the broader healthcare sector, serving pharmaceutical, biotech, academic, and public‑health customers worldwide. Its business model centers on selling hardware together with recurring consumables and software, creating high switching costs and a largely recurring revenue stream. Revvity has a global footprint in more than 160 countries and is recognized for its strong position in niche areas such as newborn screening and reproductive‑health diagnostics, positioning it as a leading “picks‑and‑shovels” supplier in the health‑science market.

Quarterly Earnings

QuarterDateEPS
Q4 FY26Feb 2, 2027 (est.)—
Q3 FY26Nov 3, 2026$1.38
Q2 FY26Jul 27, 2026$1.41
Q1 FY26May 5, 2026$1.06
Q4 FY25Feb 2, 2026$1.70

Stay ahead of RVTY earnings

Get reminders ahead of RVTY's next earnings report, so you always know when results are coming.

Other Healthcare stocks in the S&P 500